This week, AmSpa CEO, Alex R. Thiersch, JD, speaks with Taylor Siemens, NP-C, founder of Aesthetic Care NP and clinical director of Vitalyc Medspa. They discuss medical weight loss programs and protocols for offering semaglutide in your aesthetic practice. Their conversation includes:
Read more about the ongoing lawsuits filed by Novo Nordisk, maker of Ozempic and Wegovy, at the AmSpa Now blog. Stay tuned for new updates on the subject as more info becomes available.
This episode of Medical Spa Insider is sponsored by RepeatMD. Visit https://www.repeatmd.com/ to learn more!
Overcoming Medical Spa Disasters, Part 1: Marria Pooya and Greenwich Med Spa
Greatest Hits: Live From the Expo Hall of Medical Spa Show 2020
How Las Vegas is Re-opening for Events After the COVID-19 Quarantine
Keys to Medical Aesthetic Marketing and Practice Growth
A New Resource for Medical Aesthetic Education, Finances, Marketing Data and Industry Benchmarks
Growing and Expanding an Injectables Practice in the Age of COVID-19
COVID-19 Vaccines: An Epidemiologist’s Perspective
How to Be CEO of Your Medical Aesthetic Business
Understanding Medical Spa Financials
Anatomy Training for Better Injectable Results
The AmSpa Aesthetic Safety Council and Practice Guidelines
Increasing Independent Practice and Other Upcoming Medical Spa Law Trends
The Effects of COVID-19 on the Medical Spa Industry
From Trauma Surgery to Medical Aesthetics
Update on the New Stimulus Plan
Building a Medical Aesthetic Community: Interview with AmSpa’s CEO
Is OSHA a Four-letter Word?
RN Scope of Practice in Medical Aesthetics
Why Medical Spa Investing Is More Attractive Than Ever Before
Greatest Hits: How to Make Sales Your Zone of Genius
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
Organic Marketing Simplified: Effective podcasting strategy for growth and monetization
THE GO BIZ GUY
The Sigma Femme Podcast
The Prof G Pod with Scott Galloway
I am Charles Schwartz Show